Symbols / NEPH Stock $2.84 -0.35% Nephros, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
NEPH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Stock Fundamentals
Scroll to Statements
Market Cap 30.23M Enterprise Value 25.89M Income 1.19M Sales 18.79M Book/sh 0.96 Cash/sh 0.51
Dividend Yield Payout Employees 36 IPO P/E 25.82 Forward P/E 21.85
PEG P/S 1.61 P/B 2.96 P/C EV/EBITDA 20.15 EV/Sales 1.38
Quick Ratio 2.82 Current Ratio 4.06 Debt/Eq 10.42 LT Debt/Eq EPS (ttm) 0.11 EPS next Y 0.13
EPS Growth -82.40% Revenue Growth 22.20% Earnings 2026-05-07 ROA 5.76% ROE 12.71% ROIC
Gross Margin 61.87% Oper. Margin 0.38% Profit Margin 6.35% Shs Outstand 10.64M Shs Float 9.45M Short Float 0.45%
Short Ratio 0.97 Short Interest 52W High 6.42 52W Low 1.64 Beta 1.56 Avg Volume 40.03K
Volume 32.46K Target Price $7.00 Recom None Prev Close $2.85 Price $2.84 Change -0.35%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.00
Mean price target
2. Current target
$2.84
Latest analyst target
3. DCF / Fair value
$1.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.84
Low
$6.00
High
$8.00
Mean
$7.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-08-08 main Maxim Group Buy → Buy $6
2024-11-12 reit Benchmark Speculative Buy → Speculative Buy $5
2024-05-15 reit Benchmark Speculative Buy → Speculative Buy $5
2024-03-08 up Benchmark Hold → Speculative Buy $5
2021-01-26 init B. Riley Securities — → Buy $13
2019-10-24 init Benchmark — → Speculative Buy $16
2019-10-04 init Maxim Group — → Buy
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-23 KRANDEL JUDITH FINGER Chief Financial Officer 68,861 $1.71 $117,752
2026-03-23 BANKS ROBERT R JR. Chief Executive Officer 120,000 $1.44 $172,800
2026-03-16 AMRON ARTHUR H Director 3,610 $0.00 $0
2025-11-10 SPANDOW OLIVER J Director 8,036 $0.00 $0
2025-11-10 NETTIS LISA MARIE Director 1,622 $0.00 $0
2025-11-10 AMRON ARTHUR H Director 5,391 $0.00 $0
2024-12-31 SPANDOW OLIVER J Director 33,241 $0.00 $0
2024-12-31 AMRON ARTHUR H Director 22,418 $0.00 $0
2024-05-30 AMRON ARTHUR H Director 5,000 $2.22 $11,176
2024-05-16 BANKS ROBERT R JR. Chief Executive Officer 50,000 $2.24 $112,050
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
18.79
+32.67%
14.16
-0.53%
14.24
+42.74%
9.97
Operating Revenue
18.79
+32.67%
14.16
-0.53%
14.24
+42.74%
9.97
Cost Of Revenue
7.16
+31.72%
5.44
-6.75%
5.83
+11.23%
5.24
Reconciled Cost Of Revenue
7.17
+31.78%
5.44
-6.79%
5.83
+14.13%
5.11
Gross Profit
11.62
+33.27%
8.72
+3.78%
8.40
+77.66%
4.73
Operating Expense
10.48
+20.21%
8.72
-12.81%
10.00
+10.28%
9.07
Research And Development
1.34
+47.79%
0.91
+3.78%
0.87
-30.44%
1.25
Selling General And Administration
9.00
+17.25%
7.68
-13.86%
8.91
+17.36%
7.59
Total Expenses
17.64
+24.63%
14.16
-10.58%
15.83
+10.63%
14.31
Operating Income
1.15
+19000.00%
0.01
+100.38%
-1.59
+63.25%
-4.33
Total Operating Income As Reported
1.15
+19000.00%
0.01
+100.38%
-1.59
+63.25%
-4.33
EBITDA
1.35
+493.39%
0.23
+116.70%
-1.36
+65.21%
-3.91
Normalized EBITDA
1.43
+501.27%
0.24
+118.02%
-1.31
+66.88%
-3.97
Reconciled Depreciation
0.14
+1.46%
0.14
-35.98%
0.21
-39.03%
0.35
EBIT
1.21
+1241.11%
0.09
+105.72%
-1.57
+63.05%
-4.26
Total Unusual Items
-0.08
-680.00%
-0.01
+77.27%
-0.04
-168.75%
0.06
Total Unusual Items Excluding Goodwill
-0.08
-680.00%
-0.01
+77.27%
-0.04
-168.75%
0.06
Special Income Charges
0.00
Other Special Charges
Restructuring And Mergern Acquisition
Net Income
1.19
+1513.51%
0.07
+104.70%
-1.57
+78.66%
-7.38
Pretax Income
1.21
+1255.06%
0.09
+105.65%
-1.57
+63.18%
-4.28
Net Non Operating Interest Income Expense
0.14
+48.39%
0.09
+50.00%
0.06
+1133.33%
-0.01
Interest Expense Non Operating
0.00
+0.00%
0.00
-50.00%
0.00
-90.00%
0.02
Net Interest Income
0.14
+48.39%
0.09
+50.00%
0.06
+1133.33%
-0.01
Interest Expense
0.00
+0.00%
0.00
-50.00%
0.00
-90.00%
0.02
Interest Income Non Operating
0.14
+47.87%
0.09
+46.88%
0.06
+357.14%
0.01
Interest Income
0.14
+47.87%
0.09
+46.88%
0.06
+357.14%
0.01
Other Income Expense
-0.08
-680.00%
-0.01
+77.27%
-0.04
-168.75%
0.06
Other Non Operating Income Expenses
-0.04
-168.75%
0.06
Gain On Sale Of Security
-0.08
-680.00%
-0.01
+77.27%
-0.04
-168.75%
0.06
Tax Provision
0.01
-20.00%
0.01
0.00
Tax Rate For Calcs
0.00
-94.06%
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.00
+53.68%
-0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1.19
+1513.51%
0.07
+104.70%
-1.57
+77.84%
-7.11
Net Income From Continuing Operation Net Minority Interest
1.19
+1513.51%
0.07
+104.70%
-1.57
+65.41%
-4.55
Net Income From Continuing And Discontinued Operation
1.19
+1513.51%
0.07
+104.70%
-1.57
+78.66%
-7.38
Net Income Continuous Operations
1.19
+1513.51%
0.07
+104.70%
-1.57
+63.18%
-4.28
Net Income Discontinuous Operations
0.00
+100.00%
-2.83
Minority Interests
0.00
+100.00%
-0.28
Normalized Income
1.27
+1444.01%
0.08
+105.38%
-1.53
+66.84%
-4.62
Net Income Common Stockholders
1.19
+1513.51%
0.07
+104.70%
-1.57
+78.66%
-7.38
Diluted EPS
0.01
+106.67%
-0.15
+78.57%
-0.70
Basic EPS
0.01
+106.67%
-0.15
+78.57%
-0.70
Basic Average Shares
10.53
+1.34%
10.39
+0.86%
10.30
Diluted Average Shares
10.61
+2.15%
10.39
+0.86%
10.30
Diluted NI Availto Com Stockholders
1.19
+1513.51%
0.07
+104.70%
-1.57
+78.66%
-7.38
Depreciation Amortization Depletion Income Statement
0.14
+3.70%
0.14
-36.92%
0.21
-1.83%
0.22
Depreciation And Amortization In Income Statement
0.14
+3.70%
0.14
-36.92%
0.21
-1.83%
0.22
Line Item Trend 2023-12-31
Total Assets
11.86
Current Assets
8.40
Cash Cash Equivalents And Short Term Investments
4.31
Cash And Cash Equivalents
4.31
Cash Equivalents
4.03
Cash Financial
0.27
Receivables
1.50
Accounts Receivable
1.50
Gross Accounts Receivable
12.50
Allowance For Doubtful Accounts Receivable
-11.00
Inventory
2.47
Raw Materials
0.33
Work In Process
0.00
Finished Goods
2.14
Prepaid Assets
Assets Held For Sale Current
Other Current Assets
0.13
Total Non Current Assets
3.46
Net PPE
1.96
Gross PPE
2.92
Accumulated Depreciation
-0.96
Properties
0.00
Machinery Furniture Equipment
0.18
Other Properties
2.65
Leases
0.09
Goodwill And Other Intangible Assets
1.41
Goodwill
0.76
Other Intangible Assets
0.65
Other Non Current Assets
0.09
Total Liabilities Net Minority Interest
3.50
Current Liabilities
2.11
Payables And Accrued Expenses
1.67
Payables
0.91
Accounts Payable
0.87
Current Accrued Expenses
0.76
Total Tax Payable
0.04
Current Debt And Capital Lease Obligation
0.45
Current Debt
Other Current Borrowings
Current Capital Lease Obligation
0.45
Other Current Liabilities
Total Non Current Liabilities Net Minority Interest
1.39
Liabilities Heldfor Sale Non Current
Long Term Debt And Capital Lease Obligation
1.39
Long Term Debt
Long Term Capital Lease Obligation
1.39
Stockholders Equity
8.36
Common Stock Equity
8.36
Capital Stock
0.01
Common Stock
0.01
Preferred Stock
0.00
Share Issued
10.54
Ordinary Shares Number
10.54
Treasury Shares Number
0.00
Additional Paid In Capital
152.75
Retained Earnings
-144.41
Gains Losses Not Affecting Retained Earnings
Minority Interest
0.00
Total Equity Gross Minority Interest
8.36
Total Capitalization
8.36
Working Capital
6.29
Invested Capital
8.36
Total Debt
1.84
Capital Lease Obligations
1.84
Net Tangible Assets
6.95
Tangible Book Value
6.95
Other Equity Interest
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1.65
+434.35%
-0.49
-159.49%
0.83
+125.57%
-3.23
Cash Flow From Continuing Operating Activities
1.65
+434.35%
-0.49
-159.49%
0.83
+125.57%
-3.23
Net Income From Continuing Operations
1.19
+1513.51%
0.07
+104.70%
-1.57
+77.84%
-7.11
Depreciation Amortization Depletion
0.14
+1.46%
0.14
-35.98%
0.21
-39.03%
0.35
Depreciation
0.06
+19.57%
0.05
+17.95%
0.04
-58.06%
0.09
Amortization Cash Flow
0.08
-7.69%
0.09
-48.00%
0.17
-32.17%
0.26
Depreciation And Amortization
0.14
+1.46%
0.14
-35.98%
0.21
-39.03%
0.35
Amortization Of Intangibles
0.08
-7.69%
0.09
-48.00%
0.17
-32.17%
0.26
Other Non Cash Items
0.36
-20.36%
0.45
+30.70%
0.34
-3.12%
0.35
Stock Based Compensation
0.30
+93.46%
0.15
-85.46%
1.05
+7.13%
0.98
Provisionand Write Offof Assets
0.00
-100.00%
0.01
+1200.00%
-0.00
Asset Impairment Charge
0.07
-74.05%
0.26
-11.19%
0.29
-86.39%
2.17
Operating Gains Losses
0.01
+145.45%
-0.01
-0.06
Net Foreign Currency Exchange Gain Loss
0.01
+183.33%
-0.01
0.00
+100.00%
-0.06
Change In Working Capital
-0.41
+73.42%
-1.55
-418.44%
0.49
+12.96%
0.43
Change In Receivables
-0.63
-122.11%
-0.28
-28.96%
-0.22
-161.90%
0.36
Changes In Account Receivables
-0.63
-122.11%
-0.28
-28.96%
-0.22
-161.90%
0.36
Change In Inventory
-0.69
-68.30%
-0.41
-205.17%
0.39
-49.41%
0.77
Change In Prepaid Assets
-0.04
-250.00%
-0.01
-117.86%
0.06
+115.38%
0.03
Change In Payables And Accrued Expense
1.28
+387.67%
-0.45
-169.80%
0.64
+186.00%
-0.74
Change In Accrued Expense
1.02
+553.10%
-0.23
-144.66%
0.51
+437.33%
-0.15
Change In Payable
0.26
+217.73%
-0.22
-265.41%
0.13
+122.43%
-0.59
Change In Account Payable
0.26
+217.73%
-0.22
-265.41%
0.13
+122.43%
-0.59
Change In Other Current Assets
0.00
-100.00%
0.04
+216.13%
-0.03
-108.12%
0.38
Change In Other Current Liabilities
-0.34
+22.40%
-0.44
-29.24%
-0.34
+3.66%
-0.35
Investing Cash Flow
0.00
+100.00%
-0.05
+33.33%
-0.07
+45.26%
-0.14
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.05
+33.33%
-0.07
+45.26%
-0.14
Net PPE Purchase And Sale
0.00
+100.00%
-0.05
+33.33%
-0.07
+45.26%
-0.14
Purchase Of PPE
0.00
+100.00%
-0.06
+26.67%
-0.07
+45.26%
-0.14
Sale Of PPE
0.00
-100.00%
0.01
0.00
Capital Expenditure
-0.06
+26.67%
-0.07
+45.26%
-0.14
Net Other Investing Changes
Financing Cash Flow
-0.01
+0.00%
-0.01
+93.67%
-0.08
-332.35%
0.03
Cash Flow From Continuing Financing Activities
-0.01
+0.00%
-0.01
+93.67%
-0.08
-332.35%
0.03
Net Issuance Payments Of Debt
-0.01
+0.00%
-0.01
+93.67%
-0.08
+72.38%
-0.29
Issuance Of Debt
Repayment Of Debt
-0.01
+0.00%
-0.01
+93.67%
-0.08
+72.38%
-0.29
Long Term Debt Issuance
Long Term Debt Payments
-0.01
+0.00%
-0.01
+93.67%
-0.08
-426.67%
-0.01
Net Long Term Debt Issuance
-0.01
+0.00%
-0.01
+93.67%
-0.08
-426.67%
-0.01
Short Term Debt Payments
-0.07
+73.80%
-0.27
Net Short Term Debt Issuance
-0.07
+73.80%
-0.27
Net Common Stock Issuance
Proceeds From Stock Option Exercised
0.00
-100.00%
0.16
Net Other Financing Charges
0.16
Changes In Cash
1.64
+399.82%
-0.55
-181.28%
0.67
+120.17%
-3.34
Effect Of Exchange Rate Changes
0.00
+100.00%
-0.00
Beginning Cash Position
3.76
-12.70%
4.31
+18.52%
3.63
-47.88%
6.97
End Cash Position
5.40
+43.62%
3.76
-12.70%
4.31
+18.52%
3.63
Free Cash Flow
1.65
+400.73%
-0.55
-172.74%
0.75
+122.31%
-3.37
Interest Paid Supplemental Data
0.00
-50.00%
0.00
+0.00%
0.00
-89.47%
0.02
Income Tax Paid Supplemental Data
0.00
0.00
0.00
Common Stock Issuance
Issuance Of Capital Stock
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category